Melanie Sena

Melanie Sena is community editor of Pharmaceutical Technology.

Articles

Report:Positive Outlook for Investment in Global Pharma and Biotech Industry

Research from Frost & Sullivan indicates a strong comeback of IPOs suggesting a positive outlook for investment in the pharmaceutical and biotechnology industry.

FDA Targets Illegal Online Pharmacies

FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.

FDA Approves Entyvio for Ulcerative Colitis and Crohn's Disease

DA approves Entyvio, an injection to treat adult patients with moderate to severe ulcerative colitis and Crohn's disease.

Shark Antibodies Inspire Optimization of Human Antibodies

The structural analysis of shark IgNAR antibodies reveals evolutionary principles of immunoglobulins.

GE Healthcare and Promosome Sign Licensing Agreement

GE Healthcare and Promosome sign a licensing agreement that gives GE Healthcare exclusive rights to a new suite of mammalian cell line development technologies.

Spectrum Pharmaceuticals Appoints New President and COO

Spectrum Pharmaceuticals appoints Joseph Turgeon as president and COO.

Lilly to Acquire Novartis Animal Health

Eli Lilly will acquire Novartis Animal Health for approximately $5.4 billion.

Disposable Protein A Chromatography Columns

Grace's ProVance disposable Protein A chromatography column is designed for downstream purification.

Pre-Packed Chromatography Columns

OPUS technology designed to process large single-use bioreactor harvests.

Center for Biologics Evaluation and Research Relocates

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.